At $50.56, Fifth Third trades near 10 times my 2027 earnings of $5.12 a share. The Comerica savings already show in returns. Higher deposit costs and bond losses hold back the rest, so I start at hold with a $54.25 target.
Key points
- 20.6%: adjusted return on tangible equity in Q3 2026, already above the 19% goal set for 2027.
- $5.12 a share: my 2027 earnings estimate, with deposit costs rising in step with rates.
- 2.3 times: price to tangible book value (equity minus goodwill), which leaves little room for a higher multiple.
The call
The price asks for about $5.05 a share of earnings in 2027 at 10 times. That is roughly the Q4 2026 run rate held flat. The market is not paying for the expected 2027 savings from Comerica because those savings mostly show up already. It is still pricing in the risk that deposits keep getting more expensive.
Quarterly revenue, FTE, before and after Comerica ($ billions)- Reported revenue
- My estimate
Reported: company releases through Oct 19, 2026. Q4 26E from guidance midpoints; 2027E my estimates.
I land a little above the price, not far above. Interest income should keep growing about 3% a year as old fixed-rate loans and bonds reprice. Deposit costs are rising at about 55% of each rate hike, and a December hike is expected. Buybacks were paused because bond losses cut into capital. That puts modest growth at a market-like multiple.
Valuation
| Step | Figure |
|---|
| Q4 2026 earnings, guidance midpoints | $1.24 a share |
| 2027 earnings, my estimate | $5.12 a share |
| Next-twelve-month earnings in October 2027 | $5.42 a share |
| Multiple | 10 times |
| Target | $54.25 |
Ten times earnings fits a bank earning about 20% on tangible equity in a market where rates are still rising, the same multiple I used for M&T. The chart below shows the target moves about $5.40 a share for each turn of multiple, so the risk runs roughly even both ways. A gain of 7% plus a 3.4% dividend makes this a hold.
Twelve-month value at each earnings multiple ($ per share)My forward EPS of $5.42 a share times the multiple; price $50.56 on Oct 19, 2026.
Risks
- Deposit flight to higher-yield tools: watch interest-bearing deposit cost climb past 2.24% faster than loan yields rise.
- More rate hikes widen bond losses (unrealized losses already rose to $4.9 billion) and push back the $200 million to $300 million Q4 buyback: watch whether the Q4 report shows shares repurchased.
- Credit: charge-offs, meaning loans written off as losses, could rise above the 35 basis point guide. Watch the Q4 nonperforming loans, now $1.07 billion and rising.
What would change my mind
If January's 2027 guidance shows interest income growing above 6% with buybacks restarted, I would move to buy. If deposit costs outrun asset yields, I would move to sell.
On the other analysts' notes
I am keeping my hold and my $54.25 target. All four buys use 2027 earnings within about 5% of my $5.12 a share. The gap between us is the multiple: they pay 11 to 11.6 times earnings and I pay 10. Grok and Muse made the case that mattered most, that peer regional banks trade at 11 times. That argument does not move me. A higher multiple needs a trigger, and the trigger here is buybacks restarting. Buybacks were paused in September because bond losses on the balance sheet ate into capital, and those losses widen if rates rise again in December. Gemini's $5.25 also assumes 905 million shares. Getting there takes buybacks the bank has not yet made, so part of that upside counts the trigger as already pulled. GPT's 11.5 times rests on cheaper deposits holding up, which is the one thing a rising-rate market is testing right now. The January report is the test. If it shows the $200 million to $300 million Q4 buyback done and 2027 guidance pointing to interest income growing faster than 6%, I move to buy. Until then I expect modest gains plus a 3.4% dividend, which is a hold.
